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1. Introduction  
Bone density and quantity are primary conditions for the insertion and stability of dental 
implants. In cases of a lack of adequate maxillary or mandibulary bone, e.g. in terms of front 
to back depth or thickness, bone augmentation will be necessary. Lack of bone or bone 
defects can be caused by inflammation, congenital malformation, trauma or oncological 
surgery. Several procedures and materials for augmenting bone height have been developed 
to overcome the problem of a reduced amount of bone. In dentistry, bone substitution 
materials were used for the following applications: (1) socket preservation; (2) periodontal 
defects; (3) third molar extraction sites to support 2nd molars; (4) ridge augmentation; (5) 
defects following cyst removal / apicoectomies; (6) sinus lifts; (7) distraction osteogenesis; 
and (8) implant dentistry. The treatment of bone-defects and socket preservation include 
autografting (from one location to another within the same individual), xenografting (from a 
donor of another species) and allografting (from a genetically dissimilar member of the 
same species) cancellous bone. After blood, bone is the most commonly transplanted tissue. 
Worldwide, an estimated 2.2 million grafting procedures are performed annually to repair 
bone defects in orthopaedics, neurosurgery, and dentistry (Giannoudis et al. 2005). The 
increasing number of grafting procedures and the disadvantages of current autograft and 
allograft treatments (e.g. limited graft quantity, risk of disease transmission) drive the quest 
for alternative methods to treat bone defects. 
The use of synthetic bioactive bone substitute materials is of increasing importance in modern 
dentistry as alternatives to autogenous bone grafts. Various alloplastic bone substitution 
materials of different origin, chemical composition, and structural properties have been 
investigated in the last years. The materials commonly used in all approaches are ceramics, 
polymers or composites (Burg et al. 2000). These alloplastic materials are either absorbable or 
non-absorbable, as well as naturally derived or synthetically manufactured (Figure 1).  
Various types of biomaterials (minerals and non-mineral based materials as well as natural 
and artificial polymers) with different characteristics have been used for studying 
ossification and bone formation. For example, calcium phosphate ceramics include a variety 
of ceramics such as hydroxyapatite, tricalcium phosphate, calcium phosphate cement, etc. 
These mentioned ceramics have excellent biocompatibility and bone bonding or bone 
regeneration properties. Recently non-biodegradable and degradable membranes have been 
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tested for their appliance in bone defects (Zhao et al. 2000). Cell-biomaterial interactions 
depend on surface characteristics, e.g. chemistry or topography. Surface characteristics 
determine the ionic exchange dynamics and the protein attachment as well as cell 
attachment, cell proliferation and cell differentiation. 
 
 
Fig. 1. The classification of used biomaterials for bone tissue engineering modified according 
to Burg (Burg et al. 2000) 
Xenogenic grafting has been shown to be one of the most effective methods of creating bone 
in areas where there is none, whereas alloplastic graft material constitutes the second of the 
most popular forms of bone grafting material in dentistry. 
2. Bone regeneration 
Bone is a dynamic tissue that constantly undergoes remodelling. The signal that initiates 
bone remodelling has not been identified, but there is evidence that mechanical stress can 
alter local bone architecture. This can be sensed by osteocytes followed by secretion of 
paracrine factors such as insulin-like growth factor (IGF-1) in response to mechanical forces 
(Lean et al. 1996). Bone formations result from a complex cascade of events that involves 
proliferation of primitive mesenchymal cells (osteoinduction), differentiation into osteoblast 
precursor cells, maturation of osteoblasts, formation of matrix, and finally mineralization. 
Osteoblasts converge at the bottom of the resorption cavity and form osteoid which begins 
to mineralize after 13 days. The osteoblasts continue to form and mineralize osteoid until the 
cavity is filled (Hill 1998). Some of the osteoblasts differentiate into osteocytes and become 
embedded in the matrix.  
Even if pre-existing osteoblasts may help to form new bone, it is generally agreed that such 
osteoblasts only contribute a minor portion of the new bone needed in a fracture-healing 
situation. The initial event must be the chemotactic attraction of osteoblasts or their precursors 
to sites of the resorption defect. This is likely to be mediated by the release of local, biochemical 
and biophysical messengers. The second event involved in the formation phase of the coupling 
phenomenon is proliferation of osteoblast precursors. This is likely to be mediated by 
osteoblast-derived growth factors and those growth factors released from bone during the 
resorption process. The third event of the formation phase is the differentiation of the 
osteoblast precursor into the mature cell. The differentiating osteoprogenitor cells express 
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several bone matrix macromolecules, namely alkaline phosphatase, type I collagen, bone 
sialoprotein, osteopontin, Cbfa1 and osteocalcin (Hill 1998). 
It is a balance between the amount of bone resorbed by osteoclasts and the amount of bone 
formed by osteoblast (Frost 1964). Bone remodelling occurs in small packets of cells called 
basic multicellular units (BMU), which turn bone over in multiple bone surfaces (Frost 
1991). BMU consist of osteoblasts, other bone-forming cells such as osteocytes and bone-
lining cells, bone-resorbing cells - osteoclasts, the precursor cells of both, and their 
associated cells like endothelial cells and nerve cells (Papachroni et al. 2009). Osteoblasts are 
key components of the bone multicellular unit and have a seminal role in bone remodelling, 
which is an essential function for the maintenance of the structural integrity and metabolic 
capacity of the skeleton. Osteoblasts originate from the non-hematopoietic part of bone 
marrow, which contains a group of fibroblast-like stem cells with osteogenic differentiation 
potential, known as the mesenchymal stem cells (MSCs) and also referred as skeletal stem 
cells (SSCs), bone marrow stromal cells (BMSCs) and multipotent mesenchymal stromal 
cells (MMSCs) (Abdallah and Kassem 2008; Heino and Hentunen 2008). MSCs are capable of 
multi-lineage differentiation into mesoderm-type cells such as osteoblasts, adipocytes and 
chondrocytes (Dezawa et al. 2004; Luk et al. 2005). Osteoblast growth and differentiation is 
determined by a complex array of growth factors and signalling pathways. The following 
three families of growth factors influence the main aspects of osteoblast activity and induce, 
mediate or modulate the effects of other bone growth regulators: 
- the transforming growth factor-β (TGF-β) family  
- the insulin-like growth factors (IGFs) 
- bone morphogenetic proteins (BMPs) (Zhou et al. 1993; Mundy 1994; Bikle 2008). 
Furthermore, other growth factors, such as the vascular endothelial growth factor (VEGF), 
fibroblast growth factor (FGF) as well as platelet derived growth factor (PDGF) are involved 
in bone formation.  
Many growth factors involved in the natural process of bone healing have been identified 
and tested as potential therapeutic candidates to enhance the regeneration process. In vitro, 
BMPs can differentiate mesenchymal stem cells into the osteoblastic phenotype (Cheng et al. 
2003; Luu et al. 2007). Furthermore, the osteoinductive BMPs (e.g. BMP-2/-4/ and BMP-5 to 
-8) can initiate the complete cascade of bone formation when implanted ectopically (Wozney 
2002). In general, TGF-β stimulates migration of skeletal stem cells and regulates cell 
proliferation, cell differentiation, and extra cellular matrix synthesis (Bostrom and Asnis 
1998; Janssens et al. 2005). Stimulatory effects on bone healing and bone formation have 
been evaluated in various experimental settings (Janssens et al. 2005). FGFs are considered 
potent regulators of cell growth and wound healing and have mitogenic effects. The best 
studied member of FGFs is FGF-2. Although FGF-2 alone is not capable of inducing ectopic 
bone formation, it plays an important role in the regulation of normal bone healing (Marie 
2003). In various animal studies exogenous recombinant FGF-2 enhances callus formation 
and stimulates bone healing (Kato et al. 1998; Nakamura et al. 1998; Radomsky et al. 1998). 
IGFs are the most abundant growth factors produced by bone cells and are stored at the 
highest concentration of all growth factors in the bone matrix. It was shown that IGF has an 
anti-apoptotic effect on pre-osteoblast cells and enhances bone matrix synthesis (Niu and 
Rosen 2005). In animal models and clinical trials of osteoporosis, systemic IGF infusion 
showed an increase in bone formation, bone volume, and / or bone turnover (Rosen 2004). 
VEGF is considered one of the key regulators of angiogenesis during bone formation 
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(Gerstenfeld et al. 2003). In various experimental models the stimulation of the bone 
regeneration process has been shown in response to VEGF administration (Street et al. 2002; 
Eckardt et al. 2005). In addition, PDGF regulates general tissue repair as well as enhances 
proliferation of various bone cell types and angiogenesis (Hollinger et al. 2008). 
Mechanisms that promote skeletal tissue specificity are necessary, because none of these 
growth factors are specific for cells in the osteoblastic lineage and these involve interactions 
with other circulating hormones in addition to the action of specific intracellular mediators 
on bone-specific transcription factors. It is certain that bone remodelling is regulated by 
systemic hormones and by local factors (Canalis 1983), which affect cells of both the 
osteoclast and osteoblast lineages and exert their effects on the replication of 
undifferentiated cells, the recruitment of cells, and the differentiated function of cells (Hill 
1998). The following hormones are involved in bone formation: 
- Calcitonin (CT) – decreases the reabsorption of calcium from bones thereby lowering 
blood calcium levels. It can inhibit osteoclastic bone resorption and probably osteocytic 
osteolysis (Weiss et al. 1981; Wallach et al. 1993). 
- Estrogens and androgens - slow the rate of bone remodelling and protect against bone 
loss. They help retain calcium in bones, thereby maintaining a strong bone matrix. Sex 
steroids not only influence the accrual of bone mass and bone mineral density but also 
bone growth (Manolagas et al. 2002; Bertelloni et al. 2010). 
- Growth hormone (GH) - is one of the most important regulator substances for both 
bone growth and bone remodelling. It directly increases longitudinal bone growth by 
stimulating prechondrocites. GH is a polypeptide complex that regulates the processes 
of bone physiology, increases the rate of mitosis of chondrocytes and osteoblasts, and 
increases the rate of protein synthesis (collagen, cartilage matrix, and enzymes for 
cartilage and bone formation) (Ohlsson et al. 1998; Calvo-Guirado et al. 2011).  
- Insulin – increases energy production from glucose. It has been established as an 
osteoblast regulator. In bone organ culture, insulin stimulates collagen synthesis at 
periphysiological hormone concentrations (Wettenhall et al. 1969; Cornish et al. 1996). 
- Parathyroid hormone (PTH) - a major systemic regulator of bone metabolism, increases 
the reabsorption of calcium from bones to the blood, thereby raising blood calcium 
levels and increases the absorption of calcium by the small intestine and kidneys. The 
anabolic effect of intermittent PTH on bone has made it an effective treatment for 
osteoporosis in humans, where it was shown to increase bone mass and reduce fracture 
rate (Neer et al. 2001). 
- Thyroxine – increases the rate of protein synthesis and increases energy production from 
all food types. It directly stimulates the metabolic activity of bone cells and profoundly 
affects bone turnover. Thyroxine influences the responsiveness of bone cells to 1,25-
dihydroxycholecalciferol, parathyroid hormone, and calcitonin (High et al. 1981). 
Besides growth factors and regulating hormones, expression of transcription factors is 
necessary and sufficient for mesenchymal cell differentiation. Runx2 is an essential bone-
specific transcription factor. It was recently shown, that the complete Runx2 gene 
inactivation in transgenic mice leads to complete lack of intramembraneous and 
endochondral ossification owing to lack of mature osteoblasts (Komori et al. 1997). In 
addition, heterozygous Runx2 mice demonstrate specific skeletal abnormalities that are 
characteristic of the human heritable skeletal disorder cleidocranial dysplasia (Otto et al. 
1997). 
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3. Pre-conditions of bone surrogates 
Selection of graft materials is based on operator preference, type and size of the bone defect, 
resorbability of graft material as well as cost and patient acceptance. Furthermore, bone 
graft materials are generally evaluated based on their osteogenic, osteoinductive, or 
osteoconductive potential. Osteoinduction is a basic biological mechanism that occurs 
regularly, e.g. in fracture healing but also in implant incorporation (Albrektsson and 
Johansson 2001). Osteoconduction means that bone grows on a surface and is defined as the 
ability to stimulate the attachment, migration, and distribution of vascular and osteogenic 
cells within the graft material (Albrektsson and Johansson 2001). Several physical 
characteristics can affect the graft osteoconductivity, including porosity, pore size, and 
three-dimensional architecture. In addition, direct interactions between matrix proteins and 
their appropriate cell surface receptors play a major role in the host response to the graft 
material. An osteoconductive material guides repair in a location where normal healing will 
occur if left untreated (Kulkarni et al. 1971; Helm and Gazit 2005). 
The ability of a graft material to independently produce bone is termed its direct osteogenic 
potential. The main critical considerations in bone tissue-engineering scaffold design are: 
 Promotion of bone in-growth 
 Average pore sizes approximately 200-400 μm 
 Sterilization without loss of properties 
 Absorbation with biocompatible components 
 Good bony apposition 
 Correct mechanical and physical properties for application 
 Maximal bone growth through osteoinduction and/or osteoconduction 
 Adaptation to irregular wound site (malleableness) 
 Absorbation in predictable manner in concert with bone growth 
 Availability to surgeon on short notice (Peter et al. 1998; Burg et al. 2000) 
To have direct osteogenic activity, the graft must contain cellular components that directly 
induce bone formation. Polymers have been shown to be an excellent substrate for cellular 
or bioactive molecule delivery. They can differ in their molecular weight, polydispersity, 
crystallinity, and thermal transitions, allowing different absorption rates. Their relative 
hydrophobicity and percent crystallinity can affect cellular phenotype (Hollinger and 
Schmitz 1997). Various types of biomaterials (minerals and non-mineral based materials as 
well as natural and artificial polymers) with different characteristics have been used for 
studying ossification and bone formation. For example, calcium phosphate ceramics include 
a variety of ceramics such as hydroxyapatite, tricalcium phosphate, calcium phosphate 
cement, etc. Local tissue responses to polymers in vivo depend on the biocompatibility of the 
polymer as well as its degradative by-products (Hollinger and Battistone 1986). The 
mentioned ceramics have excellent biocompatibility and bone bonding or bone regeneration 
properties. They have been widely used in no or low load-bearing applications (Milosevski 
et al. 1999). Furthermore, natural polymers like collagen have been used for bone tissue 
engineering purposes (Hutmacher et al. 2001a; Lauer et al. 2001). Recently non-
biodegradable and degradable membranes have been tested for their appliance in bone 
defects (Zhao et al. 2003). Scores of artificial polymers of diverse character are already in use 
for bone supply. One of them, poly(3)hydroxybutyrate (PHB) due to its form stability 
combined with little inflammatory response after implantation, may serve as a scaffold for 
tissue engineering (Gogolewski et al. 1993; Schmack et al. 2000). 
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4. Alloplastic materials in dentistry  
Today, the above-mentioned clinical problems are solved by bone grafting. Autogeneic bone 
graft from the iliac crest is the main source of trabecular bone. It has a good osteoinductive 
capacity, but the sources are limited and the harvest procedure causes postoperative 
discomfort to the patient. Allogeneic bone is also widely used but provides mainly 
osteoconductive properties. Moreover, despite of extensive testing, there are still potential 
risks for transmitting diseases. Synthetic or alloplastic materials are alternative materials to 
avoid the drawbacks of autografts or allografts, because alloplastic materials show very little 
risk of morbidity and mortality. Alloplastic materials are divided into two main groups: (1) 
non-resorbable materials that acts as replacement bone and (2) resorbable frameworks or 
scaffolds for bone to grow into at its normal rate. A large percentage of alloplastic 
biomaterials are based on one raw material, such as hydroxyapatite (HA) and tri-calcium 
phosphate (TCP) or bioactive silicates (SiO2). Recent developments have focused on 
composites with different chemical phases, such as HA+TCP (Straumann® BoneCeramic, 
Straumann, Freiburg, Germany), SiO2+HA (Nanobone®,Artoss, Rostock, Germany) or 
SiO2+Ha+TCP (BonitMatrix®, DOT, Rostock, Germany). 
4.1 Homogenous chemical composition  
Until now HA-based biomaterials are the most abundant materials used in modern bone 
substitution. At the moment calcium phosphate cements play a secondary role in dentistry, 
although they often have an excellent biocompatibility (Noetzel and Kielbassa 2005). For HA 
scaffolds both pore size and porosity have effects on mineralisation and bone formation 
(Harris and Cooper 2004; Kruyt et al. 2004). 
In vitro testing is used primarily as a first stage test for acute toxicity and cytocompatibility. 
A precondition for osteoconductivity and osteoinductivity are proliferating cells. Reichert 
and coworkers could show that neither Cerasorb® (TCP; Curason AG, Sonneberg, 
Germany), Geistlich Bio-Oss® (HA; Geistlich Pharma, Wolhusen, Germany) nor Perioglas® 
(SiO2; Novabone, Jacksonville, U.S.A.) has a negative influence on cellular proliferation, as 
compared to the control (Reichert et al. 2009). In fact, the tested bone substitution materials 
led to an increased AlamarBlue reduction over the observation period of 7d. Only 
PerioGlas® showed slight, but not significant decrease in AlamarBlue reduction, compared 
to controls (Reichert et al. 2009). The effect on the proliferation of osteoblast in vitro was 
investigated using phytogene HA (Algipore®), TCP (Bio-Base®) and bovine HA (Bio-Oss®). 
Kübler et al. have found that human osteoblast cells seeded with Bio-Oss® showed the lowest 
proliferation and differentiation rate after comparison with the other tested bone graft 
materials (Kubler et al. 2004). Furthermore, there were no obvious differences in cell migration 
and growth behaviour between BioOss® and Vitoss® scaffolds, but significantly higher 
osteocalcin expression in cells seeded on BioOss® scaffolds (Payer et al. 2010). In contrast, DNA 
content, LDH (lactate dehydrogenase) and alkaline phosphatase activity as well as expression 
of bone-related genes, such as alkaline phosphatase, osteonectin, osteopontin and bone 
sialoprotein II revealed proliferation and osteogenic differentiation of osteoblasts on 
Cerasorb®, but not on BioOss® during cultivation over 28 days (Bernhardt et al. 2010). 
Bioactive glass ceramic was seeded with human primary osteoblasts and evaluated after 2, 6 
and 12 days. Incubation with Bioglass 45S5 increased human osteoblast proliferation to 
155% as shown by flow cytometric analysis (Xynos et al. 2000b). Analysis of osteoblast 
specific markers, such as alkaline phosphatase and osteocalcin indicate that Bioglass 
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advanced osteoblast augmentation. Furthermore, expression of IGF2 was 2,9fold increased 
compared to control cells (Xynos et al. 2000a).  
However, in vitro characterization is not able to demonstrate the tissue response to 
materials. Animal models are essential for evaluating biocompatibility. Bone substitution 
materials, such as hydroxyapatite and -tricalcium phosphate were shown to be 
osteoinductive (Okumura et al. 1997; Habibovic et al. 2008; Sun et al. 2008). The in vivo bone-
regenerative capacity of calcium silicate was investigated in rabbits and results were 
compared with TCP. Micro-CT and histomorphometric analysis showed resorption and 
newly formed bone with both materials, but resorption as well as bone formation of calcium 
silicate was higher than that of TCP (Xu et al. 2008). Wistar rats were used to histologically 
evaluate the healing of surgically created defects on the tibia after implantation of bioactive 
glass. Bioactive glass promoted comparable bone formation independently of the size of 
glass granules (Macedo et al. 2005). Also new bone formation was found after implantation 
of NovaBone 45S5 bioglass particulate (NovaBone, Jacksonville, USA) in sheep. In addition, 
acute as well as chronic inflammatory reactions were associated with the use of these glass 
granules (Kobayashi et al. 2010). Furthermore, cylindrical porous hydroxyapatite implants 
were implanted in rabbit femurs. Histological analyses of bone sections with toluidine blue 
showed new bone formation (Damien et al. 2003). Various publications discussed the use of 
porous hydroxyapatite in maxillary sinuses. Histologically, the grafted sinuses exhibited a 
significant amount of new bone formation. The porous hydroxyapatite granules appeared 
integrated with the new formed bone (Browaeys et al. 2007).  
To date, predominantly histological staining and immunohistochemical analyses were used 
to study the behaviour of bone substitute materials on bone graft healing. Only a few 
numbers of studies present the molecular mechanisms of bone formations associated with 
bone substitutes. Recently it was shown, that bovine hydroxyapatite (HA) and -tricalcium 
phosphate (-TCP) up-regulate the expression of Runx2, Alpl and osteocalcin in biopsies 
from human jaws (Gotz et al. 2008). 
Calcium phosphate cements and sintered ceramics as well as calcium sulphate cements and 
bioglass have been used as BMP carriers (del Real et al. 2002; den Boer et al. 2003; Kroese-
Deutman et al. 2005). Synthetic porous hydroxyapatite might be providing a delivery 
system for bioactive agents. It was recently shown that the supplementation of a synthetic 
porous hydroxyapatite with IGF-1 significantly increased new bone formation and bone 
mineral apposition rate compared with hydroxyapatite alone (Damien et al. 2003). In 
contrast, the resorption of IGF1, TGFbeta1 or bFGF onto a carrier of TCP does not enhance 
new bone formation (Clarke et al. 2004). A multi-centre, randomized clinical trial using 
recombinant human platelet-derived growth factor with -TCP for the treatment of intra-
osseous periodontal defects showed significantly higher extent of linear bone growth and 
per cent bone fill compared to -TCP alone after six months (Jayakumar et al. 2011). 
An example for commercially available products containing growth factors is Gem 21S 
(Osteohealth, Shirley, USA), -tricalciumphosphate and recombinant human PDGF. 
4.2 Composites with different chemical phases 
Advances in biomaterial fabrication have introduced numerous innovations in designing 
scaffolds for tissue engineering. The combination of different bone substitution materials is 
an important research topic. Biomaterials on the basis of calcium phosphates are most 
widely used in craniofacial bone surgery and considered to be biocompatible, non-
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immunogenic and osteoconductive (Ruhé et al. ; Abukawa et al. 2006; Weinand et al. 2006). 
It is well know that the surface topography has an influence on cell attachment. Figure 2 
showed surface topographies of three different commercially available bone substitution 
materials, especially Cerasorb®, Straumann® BoneCeramic and NanoBone®. 
 
 
Fig. 2. Scanning electron micrographs of different biomaterials on the basis of calcium 
phosphates at different magnifications. (A) Cerasorb® (Curason AG, Germany), (B) 
Straumann® BoneCeramic (Straumann, Freiburg, Germany), (C) NanoBone® (Artoss, 
Rostock, Germany) 
The composition of bioceramics influences the cell attachment and proliferation. It was 
shown that incorporation of zinc or silicate in calcium phosphate ceramics is followed by an 
increase of osteoblast attachment and proliferation (Ishikawa et al. 2002; Thian et al. 2005), 
whereas carbonate had contradictory effects on these cells (Redey et al. 2000).  
Viability, proliferation and growth characteristics of fibroblasts cultured together with 
NanoBone® and Straumann® BoneCeramic were analysed over a period of 28 days. 
Fibroblast viability does not show any differences between cells incubated with the different 
bone graft materials and the control cells. Electron microscopy showed that fibroblast cells 
grew and proliferated at the surface of both bone graft materials (Kauschke et al. 2006). The 
same results could be observed by Reichert and coworkers (Reichert et al. 2009). They show 
no differences in the cellular proliferation between control cells and cells incubated with 
Straumann® BoneCeramic, NanoBone® and BonitMatrix® (Reichert et al. 2009). Furthermore, 
endothelial cells predominantly spread on BonitMatrix® and cells expressed endothelium-
specific surface marker proteins (Thimm et al. 2008). 
The biocompatibility of Straumann® BoneCeramic, NanoBone® and BonitMatrix® were 
tested using different animal models. A rapid vascularization and good integration within 
the peri-implant tissue was shown for BonitMatrix® after subcutaneously implantation in 
Wistar rats (Ghanaati et al. 2010). 
In vivo studies using the mouse dorsal skinfold chamber model revealed a high 
biocompatibility comparable to that of cancellous bone for NanoBone®. Both NanoBone 
A B C 
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granules and plates do not show any venular leucocyte activation after implantation. 
Furthermore, signs of angiogenesis could be observed (Abshagen et al. 2009). Vascularization 
as well as osteoneogenesis after implantation of NanoBone® was observed using guinea pigs 
(Punke et al. 2008). Our own group could establish a FE model of remodelling processes 
occurring in a bone area provided with bone graft substitutes (Gedrange et al. 2008). MicroCT 
images revealed specimen changes in the spongious and compact areas provided with the 
bone substitution material (Figure 3). The use of NanoBone® as bone substitution material 
seems to decrease the bone atrophy after teeth extraction in pigs as compared to untreated 
alveolars, but the reduction is not significant (Figure 4). 
 
 
Fig. 3. MicroCT images of embedded bone specimens showing the remodelling of the area 
provided with NanoBone®. (A) NanoBone treated animal; (B) control animal (Gedrange et 
al., 2008). 
 
 
Fig. 4. Measurement of alveolar bone atrophy 70 days after teeth extraction and animal 
treatment with or without NanoBone® 
A B 
NanoBone® control 
NanoBone® control 
atrophy (cm) 
www.intechopen.com
 
Implant Dentistry – The Most Promising Discipline of Dentistry 
 
26
The ideal substrate for the synthesis of bone should be able to promote the expression of the 
osteoblastic phenotype as well as provide a template for bone deposition (Kaufmann et al. 
2000). An osteoblastic phenotype expression on the surface of hydroxyapatite ceramics, with 
subsequent gene expression of osteocalcin was found (Okumura et al. 1997). Recently it has 
been shown that OSSA NOVA and BONITmatrix® could stimulate bone regeneration of 
surgically created cranial defects in rats, but OSSA NOVA leads, in comparison with 
granular BONITmatrix®, to an accelerated more comprehensive bone regeneration (Kunert-
Keil et al. 2009). Studies from our lab demonstrated an increased expression of the IGF1 
mRNA in cranial defects treated with BONITmatrix® and OSSA NOVA (Gredes et al. 2010a). 
The increase in the IGF1 expression was followed by an accelerated, more comprehensive 
bone regeneration using both synthetic biomaterials consisting of calcium phosphates 
embedded in a silica matrix (Gredes et al. 2010a). Furthermore, Real-time RT-PCR analyses 
showed that the amount of the osteocalcin and Alpl mRNA was significantly increased after 
treatment with BONITmatrix®. It was recently shown that mesenchymal stem cells 
differentiated to osteoblasts within 14 days on hydroxyapatite and BONITmatrix® in 
expansion medium with and without osteogenic differentiation additives (Muller et al. 
2008). Cells revealed a higher Alpl activity and increased mRNA expression of osteocalcin 
and collagen 1 (Muller et al. 2008). Another bone graft material consisting of nanocrystalline 
hydroxyapatite embedded in a porous silica gel matrix, Nanobone® was implanted in the 
mandible of minipigs. It was shown that Nanobone® is able to stimulate the differentiation 
of bone cells into osteoblasts and osteoclasts, because osteocalcin, alkaline phosphatase, 
osteopontin and BMP-2 were located in newly formed bone and focally in particles (Gerber et 
al. 2006). Furthermore, the matrix of all Nanobone® granules showed very strong 
immunoreactivity of osteocalcin and alkaline phosphatase in human jaw bone augmented 
with Nanobone® (Gotz et al. 2008). In addition, two other common markers for osteogenesis, 
mineralization and bone remodelling, namely Runx2 and Phex were analysed. Similar to the 
outcomes of other bone substitution materials like NanoBone® and their influence on bone 
healing process (Gotz et al. 2008), the expression of Runx2 gene was unaltered after application 
of BONITmatrix® and OSSA NOVA. Otherwise BONITmatrix® slightly increased the 
expression of the osteogenic transcription factor Runx2 in mesenchymal stem cells (Muller et 
al. 2008). In addition, it was suggested that diverse forms of hydroxyapatite nanoparticles may 
differentially affect the osteoblast cell function as shown on gene and protein levels (Xu et al. 
2009).  That NanoBone® could up-regulate the expression of Runx2, Alpl and osteocalcin was 
also shown in sinus lift procedures in rabbits (De Souza Nunes et al. 2010). 
The degree of osteoclast activity on the most hydroxyapatite containing scaffolds depends 
on material qualities such as crystal size and surface roughness (Rumpel et al. 2006). 
Therefore the silica gel matrix granules of NanoBone® were replaced by an organic matrix 
by accompanying osteoblastic and osteoclastic relationships. Bio-Oss®, another type of 
hydroxyapatite material derived from bovine bone, is also degraded by osteoclasts with 
ruffled borders and acid phosphatase activity (Rumpel et al. 2006). The osteoclast-like cells 
are not only localized along the surface of the newly formed bone but also directly on the 
biomaterial. In the case of Bio-Oss® signs of osteoclastic resorption were evident in the 
formerly vascular osteon channels not surrounded by bone lamellae. Contrastingly, 
osteoclast attached to NanoBone® granules also occurred in defect regions without visible 
bone formation (Rumpel et al. 2006). Similar findings showed osteoclast-like cells on the 
surface of the NanoBone® bodies as well as on newly formed bone in human jaw bone 
augmented with Nanobone®. An osteoclastic as well as osteoblastic compartment could be 
observed after TRAP staining (Gotz et al. 2008).  
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Results of clinical studies using bone graft materials have recently shown that the implant 
success rate was 100% after three years when NanoBone® was used as grafting material. 
Furthermore the periotest values indicated a solid osseointegration (Heinemann et al. 2009). 
4.3 Polymers 
Tissue repair and regeneration by tissue engineering is dependent on the use of 
biodegradable polymer scaffolds which serve as a carrier matrix for bioactive substances or 
for incorporated cells. The adhesion of cells to bioresorbable scaffolds and the proliferation 
of cells on these scaffolds are important components for tissue engineering projects and play 
a fundamental role in regulating cell differentiation, growth and survival. Biodegradable 
polymers have displayed several properties of a suitable implant scaffold for the growth of 
osteoblast precursor cells. The ideal polymer would satisfy the following criteria: i) fill 
defects of various sizes and shapes, ii) mechanical and physical properties for a particular 
application, iii) a long shelf life, and iv) biocompatible degradation products.  
Polymers are large organic macromolecules composed by many monomers in a regular 
pattern (structural units). Cellulose, collagen, agarose, chitin or hyaluronan are members of 
natural polymeric materials or so-called biological polymers. Natural polymers like collagen 
have been used for bone tissue engineering purposes (Hutmacher et al. 2001a). The most 
widely used bioresorbable materials are polymers of monocarboxylic acid derivates. A 
number of natural and synthetic polymers, such as poly-lactid acid (PLA), poly-glycolic acid 
(PGA), polyurethane (PU), and polycaprolactone (PCL), are in use as tissue scaffolds 
(Kiremitci and Piskin 1990; Vunjak-Novakovic et al. 1998; Hayashi et al. 2008). Recently 
these materials have been joined by linear polyesters of microbiological origin –
polyhydroxykanoates (PHA). Local tissue responses to polymers in vivo depend on the 
biocompatibility of the polymer as well as its degradative by-products (Hollinger and 
Battistone 1986). 
At the moment, two polymers are commercially available as a bone substitution material, 
first a PLA granulate (TruGraft™, Osteobiologics, San Antonio, U.S.A.) and second 
NovoSorb (PolyNovo Biomaterials, Port Melbourne, Australia). 
The poly(-hydroxy acid) polymers such as PLA, polygylcolide (PLG) and their copolymers 
PLGA are the most commonly used synthetic polymers to deliver BMPs (Isobe et al. 1999). 
Additional polymers used as BMP delivery systems include polyanhydrides, polypropylene 
fumurate, polyethylene glycol-PLA as well as polyphosphate (Lucas et al. 1990; Miyamoto et 
al. 1992; Renier and Kohn 1997; Behravesh et al. 1999). Incorpoartion of BMP-2 and BMP-7 in 
polycaprolactone suppressed bone marrow mesenchymal stem cell proliferation and 
increased the alkaline phosphatase activity (osteogenic differentiation) (Yilgor et al. 2010). 
An in vivo study determined the effects on osseointegration when polycaprolactone with 
BMP-2 coating was applied to bone screws. BMP-2 within the polycaprolactone coating did 
not stimulate osteogenesis (Niehaus et al. 2009). In contrast, using PCL scaffold, platelet-rich 
plasma and recombinant human BMP-2, a critical-size defect in the anterior mandible of a 
71-years-old female patient was regenerated using de novo-grown bone (Schuckert et al. 
2009). 
4.3.1 Poly-3-hydroxybutyrate (PHB) 
The most widespread and best studied polyhydroxyalkanoat (PHA) is the lipidic polymer, 
poly-3-hydroxybutyrate (PHB), which is found in the plasma membranes of Escherichia coli 
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complexted to calcium polyphosphorate (Reusch and Sadoff 1983). Different bacterial types 
of microorganisms produce PHB from renewable sources, e.g. sugar and molasses, as 
intracellular storage materials. PHB is an ideal biomaterial, because it is a biodegradable 
polyester and completely degrades in D,L-b-hydroxybutyrate (HB), a normal component of 
blood and tissue (Miller and Williams 1987; Suwantong et al. 2007). PHB is perfectly 
isotactic viz. the monomers have all branch groups on the same side of the polymeric chain 
and are oriented in the same way (Figure 5).  
 
 
Fig. 5. Schematically illustration of a PHB monomer. The PHB monomer consists of 
hydroxybutyric acid (C4H6O2 units) and a methyl group as side chain. Grey = carbon 
molecule; white = hydrogen molecule, red = oxygen molecule. 
The biocompatibility of PHB has been confirmed in vitro, in cell cultures of various origins. 
It was found that mouse fibroblast cells and chondrocytes do not grow very well on 
microbial PHB films (Deng et al. 2002; Yang et al. 2002). PHB showed a high degree of 
crystallization and this rapid crystallization generates pores and protrusions on the PHB 
surface film. It was speculated that this surface could prohibit the attachment and growth of 
mammalian cells (Zhao et al. 2003). It is well known that biocompatibility of bio materials 
depends not only on the chemical structure but, to a large extent, on the size. Suwantong 
and coworker could show using indirect cytotoxicity assessment that PHB fibre mats were 
acceptable to both mouse L929 fibroblast cells and mouse Schwann cells (RT4-D6P2T) 
(Suwantong et al. 2007). Mouse fibroblast cells cultured with polymeric PHB microspheres 
revealed no cytotoxic effects which were indicated by the absence of changes in the cell 
morphology, cell viability and proliferative activity (Shishatskaya and Volova 2004). In 
addition, human osteoblast cells grow very well on PHB embroidery (Mai et al. 2006). 
Several in vivo studies have shown that PHB may serve as a scaffold for tissue engineering 
due to its excellent biocompatibility as evidenced by lack of toxicity and compatibility with 
tissue and blood (Saito et al. 1991; Clarotti et al. 1992; Gogolewski et al. 1993; Schmack et al. 
2000; Mai et al. 2006; Mack et al. 2008; Gredes et al. 2009). PHB sheets did not caused any 
inflammation in the chorioallantoic membrane of the developing egg (Saito et al. 1991). In 
mouse tissues no acute inflammation, abscess formation, or tissue necrosis was observed 
after subcutaneously implantation. In contrast, mononuclear macrophages, proliferating 
fibroblasts, and mature vascularized fibrous capsules were typically found (Gogolewski et 
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al. 1993). Furthermore, PHB sutures implanted intramuscularly did not cause any acute 
vascular reaction or inflammation, necrosis calcification of the fibrous capsule or malignant 
tumour formation in rats (Shishatskaya et al. 2004). On the other hand, implantation of PHB 
implants significantly increased the mRNA expression of VEGF (vascular endothelial 
growth factor), IGF1 and IGF2 (insulin-like growth factor) and decreased the GDF8 (growth 
differentiation factor 8; myostatin) mRNA amount in Musculus latissimus dorsi of rats 
(Table 1) (Gredes et al. 2009).  
 
Tested gene mRNA expression (gene/-actin) 
 
 controls 6 weeks of 
treatment 
12 weeks of 
treatment 
VEGF 3.9 ± 1.0 6.2 ± 1.6 *  
IGF1 14.2 ± 3.0 29.0 ± 7.0 * 19.2 ± 3.0 * 
IGF2 5.5 ± 1.8 8.2 ± 1.8 *  
GDF8 4.8 ± 1.6 2.9 ± 1.0 * 3.3 ± 0.8 * 
Table 1. Relative expression of the VEGF, IGF1, IGF2 and GDF8 mRNA in M. latissimus 
dorsi of control rats and in M. latissimus dorsi of rats 6 and 12 weeks after PHB scaffold 
implantation. Mean ± S.E.M. are given. Students t-test * = p < 0.05. 
In addition, PHB scaffolds showed synergistic effects with the surrounding muscle, because 
of an increase in the slow myosin isoform after implantation (Mack et al. 2008). Another 
study showed ectopic bone formation in nude rats after intramuscular implantation of PHB 
embroidery seeded with human osteoblast cells (Mai et al. 2006). The osteogenic potential of 
different PHB scaffolds was also shown in nude rats (Rentsch et al. 2009). In mini pigs PHB 
was used for covering defined bone defects in the anterior skull base including a Dura mater 
lesion. The anterior skull base bone defect was completely closed after 9 months. 
Furthermore no reaction or adhesions between brain and PHB or Dura mater and PHB was 
observed (Bernd et al. 2009). 
PHB patches were used to close experimentally induced atrial septal defects in calves. 
Twelve months postoperatively no shunt or sign of infection was found. This experimental 
model thus prompted formation of regenerated endothelial tissue and complete degradation 
of the PHB patches (Malm et al. 1992).  Recently it was shown that PHB can be used as an 
alternative to epineural suturing in the treatment of peripheral nerve injuries at the 
wrist/forearm level of the arm (Aberg et al. 2009).  
4.3.2 Polylactid (PLA) 
Among the family of biodegradable polyesters, polylactides have come to the fore because, 
they are produced from renewable resources, they are biodegradable, have high mechanical 
performance and very low or no toxicity. The degradable material PLA is applied in 
dentistry as Guided Tissue/Bone Regeneration membranes even though these membranes 
do not have any significant biological function such as the facilitation of cell adhesion. 
Polylactic acid or polylactide (PLA) is the most commonly used biodegradable, 
thermoplastic, aliphatic polyester derived from renewable resources in surgery especially in 
osteosynthesis (Ashammakhi et al. 2003). PLA can be used for biomedical purposes because 
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of its biodegradability in contact with biological tissues (Rimondini et al. 2005). Polylactide 
acid is degraded by hydrolysis or specific cleavage of oligopeptides (Drury and Mooney 
2003). It is known that the degradation product of PLA, lactic acid, is normally present in the 
body, can enter the tricarbonxylic acid cycle and is excreted as H2O and CO2 (Gunatillake 
and Adhikari 2003). On the other hand degradation products of PLA are partially cytotoxic  
(Nesic et al. 2006).  
In our own experiments we could show that cultivation of L929 mouse fibroblast cells with 
PLA membranes significantly decreased cell proliferation and increased the amount of 
death cells compared to control cells. Our results are in agreement with findings from Yang 
et al (Yang et al. 2002). They show that growth of L929 cells was poor on PLA films. The 
numbers of adhered cells cultured on PLA were significantly lower than those on control 
disks in early periods of incubation but became comparable after 21 days (Iwamatsu-
Kobayashi et al. 2005). Human keratinocytes delayed growth has been shown on a PLA film 
with respect to culture on standard tissue culture polystyrene, even though the same 
plateau level was observed after 2 weeks (Garric et al. 2005). Former in vitro studies have 
shown that osteoblast cells are able to attach well to PLA or poly-glycolic acid (PGA) 
(Ishaug et al. 1994). We could demonstrate that primary osteoblast cells growth on PLA 
membranes (Figure 6).  
 
 
Fig. 6. Scanning electron micrograph of osteoblast cells (PO62) growing on a PLA 
membranes. Heterogenous morphology of these cells was observed after 10 days of cell 
culture. Bars = 300 µm 
Collagen coating and NaOH treatments of the PLA film improved skin cell adhesion and 
proliferation but their extent depends usually on the culture time (Garric et al. 2005). 
Furthermore, an enhanced 3-dimensional porous structure of PLA coated with collagen 
showed a significantly higher amount of initial cell attachment than PLA porous scaffold 
without collagen immobilization (Fuse et al. 2009). Other PLA surface modifications with 
chloric acid mixture solution increased the surface wettability and with it the cell adhesion on 
the surface (Lee et al. 2002). In contrast, human RT-112 cells did not show any differences in 
the proliferation rate after incubation with PLA alone or PLA-copolymers (Holzl et al. 2000).  
In vivo biocompatibility of poly(L-lactide) resorbable mesh was shown in rats. It was found 
that PLA induces important immunological reaction. Amongst others PLA caused mild 
 PLA membrane 
 Osteoblast cell 
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inflammatory response by infiltrating mononuclear and polynuclear inflammatory cells in 
animals (de Tayrac et al. 2008). Furthermore, stereocomplexed PLA nanofibers induced 
milder inflammatory reaction than poly(L-lactide) nanofibers after subcutaneous 
implantation in rats (Ishii et al. 2009). 
To date, predominantly histological staining and immunohistochemical analyses were used 
to study the behaviour of bone substitute materials on bone graft healing. Only a few 
numbers of studies present the molecular mechanisms of bone formations associated with 
bone substitutes. Recently it was shown that the expression of type I and type II collagen 
was increased in human mesenchymal progenitor cells as well as adipose stem cells seeded 
on PLA (Heckmann et al. 2007; Maenpaa et al. 2010). PLA nanofibres possessed a growth 
inhibitory effect on human tendon derived fibroblasts and no meaningful influence on the 
gene expression of collagen I was observed (Theisen et al. 2010). Furthermore, PLA 
nanofibres tend to result in a down-regulation in bone morphogenetic protein 2 (BMP-2) 
and VEGF expression during the period of human mesenchymal stem cell differentiation 
towards osteoblasts (Schofer et al. 2009). On the other hand PLA membranes do not have 
any influence on the gene expression of different growth factors, collagen I and II as well as 
myostatin after subcutaneously implantation in rats (Gredes et al. 2010b).  
4.3.3 Polycaprolactone (PCL) 
Polycaprolactone (PCL), a thermoplastic polymer derived from the chemical synthesis of 
crude oil, has a very low melting point of about 60°C and degrades by hydrolysis of its ester 
linkage under physiological conditions. Polycaprolactone has also been regarded as a tissue-
compatible biodegradable polymer with good mechanical properties (Khor et al. 2003). PCL 
has been proven to be a tissue-compatible biodegradable polymer with satisfying 
mechanical properties although it is not very favourable for cell growth because of its 
intrinsic hydrophobicity and lack of bioactive functional groups (Zhu et al. 2002). In vitro 
studies showed that human calvarial periosteal cells attached and proliferated on PCL 
membranes with the formation of extracellular matrix (Schantz et al. 2002). Further studies 
were conducted with primary human fibroblast cells. Light, environmental scanning 
electron, and confocal laser microscopy as well as immunohistochemistry showed cell 
proliferation and extracellular matrix production on the polycaprolactone surface in the first 
culturing week. Over a period of 3-4 weeks in a culture, the fully interconnected scaffold 
architecture was completely 3D-filled by cellular tissue (Hutmacher et al. 2001b). Human 
primary craniofacial cells proliferated on PCL as shown by DNA-assay and collagen-I 
staining. Short- and long-term attachment studies demonstrated the expression of osteoblast 
cell markers on the PCL (Gough et al. 2003). Figure 7 illustrates a natural cover of a PCL 
membrane with primary osteoblast cells after 10 d of cell culture. 
On the other hand, decreased fibroblast cell density was  present by Vance et al. after 5 days 
of treatment with NaOH-modified PCL (Vance et al. 2004). These findings are in agreement 
with our own observations that mouse fibroblast cells incubated with PCL membranes 
showed a significantly decreased proliferation rate and a higher amount of death cells as 
compared to control cells. 
The ability of PCL to repair bone defects were tested in white rabbits. Bone defects of 4.5 x 12 
mm in the bilateral femoral condyle were prepared and PCL cylinders implanted into the 
defects. After 3 to 12 months of implantation, it was shown that bone defects were filled with 
new bone on the PCL-surface, and no inflammatory reaction appeared. Furthermore, the bone 
mineral density was greater in the PCL treated animals compared to untreated control group 
(Aahmat et al. 2005). PCL has a good biocompatibility and high osteoinductivity. 
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Fig. 7. Transmission microscopy of osteoblast cells (PO62) growing on a PCL membrane. 
Normal morphology of these cells was observed after 10 days of cell culture. Magnification: 
x 200. 
To increase the osteoinductivity and osteoconductivity of PCL scaffolds, the PCL surface 
was modified. Previously, PCL-tricalcium phosphate scaffolds were developed and 
implanted into rat femoral defects. Histological evaluation illustrated infiltration of 
vascularized connective tissue and bone in treated rats, whereas the bone in-growth of 
untreated defects is minimal (Rai et al. 2007a). Polycaprolactone-20% tricalcium phosphate 
(PCL-TCP) scaffolds were assessed for the treatment of critical-sized defects of the 
mandible. Micro-CT measurements showed an increase in the bone volume fraction in 
defects grafted with scaffolds. The increase in the bone volume fraction was more 
pronounced after combination of the PCL-TCP scaffolds with platelet-rich plasma (Rai et al. 
2007b). Another modification is the incorporation of hydroxyapatite (HA) particles in PCL 
scaffolds. These PCL/HA scaffolds increase the expression of osteogenic differentiation 
markers, such as type I collagen and osteocalcin in an in vitro model. Furthermore, the use 
of the PCL/HA scaffolds in a mouse calvarial model showed significantly greater amounts 
of new bone compared to pure PCL scaffolds (Chuenjitkuntaworn et al. 2010). 
4.3.4 Collagen 
Natural polymers used in bone tissue engineering include collagen, fibrin, alginate, silk, 
hyaluronic acid, and chitosan (Hutmacher et al. 2001a). Many of the naturally occuring 
animal-derived polymers are components of the extracellular matrix. They are 
biocompatible, bioresorbable and can be formulated into many configurations with variable 
residence time using enzymatic treatment and chemical crosslinking. Collagen is the most 
abundant extracellular matrix protein and component of connective tissue. Collagen, in the 
form of elongated fibers, is mostly found in tendon, ligament and skin, as well as in cartilage 
and bone. The collagen used in dental procedures is readily isolated and purified from 
various animal species by enzyme treatment. Collagen type I is the main organic component 
that is originally secreted by osteoblasts, which then becomes mineralized at a later stage of 
bone development. Collagen has been actively investigated as a favourable artificial 
environment for bone ingrowth. It was shown that endothelial cells adherent, spread and 
proliferated on a collagen membrane (Lycoll®, Resorba, Nuernberg, Germany) (Breithaupt-
PO62 cell culture 
PCL membrane 
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Faloppa et al. 2006). Twardowski and co-workers found that type I collagen potently 
stimulates angiogenesis in vitro and in vivo (Twardowski et al. 2007). Furthermore, 
mesenchymal stem cell osteogenic differentiation was demonstrated on collagen scaffolds 
(Donzelli et al. 2007; Schneider et al. 2010; Jurgens et al. 2011). Alveolar ridge augmentation 
was found utilizing collagen wound dressing, so called COLLACOTE® (Zimmer Dental, 
Carlsbad, USA) (Ceravolo et al. 1987). 
Type I collagen gel matrix was used for nasal reconstruction in rats. Histological sections of 
the collagen implant revealed restoration of the nasal anatomy with a thin plate of immature 
bone (Lindsey et al. 1996; Toung et al. 1999). Recently it was shown that resorbable collagen 
membranes can be used for guided bone regeneration after apicectomy or around dental 
implants. Both studies demonstrate that quantity and quality of new bone formation were 
much better in bone defects covered with collagen compared to untreated bone defects (Fei 
et al. 2008; Dominiak et al. 2009). At the moment two collagen-based bone augmentation 
materials are commercially available: Foundation (J. Morita USA, Inc.) and 
COLLAPLUG® (Zimmer Dental, Carlsbad, USA). Foundation, an absorbable atelo-
collagen sponge consists of 85 to 95% bovine collagen type I and 5 to 15% bovine collagen 
type III and has been used with great success since 1998 in Japan. Using rats it was shown 
that TERUPLUG® (different brand name for Foundation) is able to stimulate 
endochondral ossification within two weeks after implantation into the calf muscle. Alkaline 
phosphatase activity and the calcium content had increased markedly in treated rats (Shinji 
et al. 2003). In addition, four weeks after implantation of TERUPLUG® in rabbit cranial 
defects a lot of newly formed collagen fibers around the inserted material were observed. 
Newly formed and matured bone was found eight weeks after implantation of 
TERUPLUG® compared to untreated animals (Kim et al. 2008). TERUPLUG® was used for 
maxillary sinus augmentation in rabbits. Gradually increased new bone formation was 
observed after 4, 12 and 24 weeks (Marukawa et al. 2011). In contrast, little or no new bone 
formation was observed on the maxillary sinus floor at six months following sinus 
membrane elevation and support with COLLAPLUG® in humans (Ahn et al. 2011).  
Despite the good in vitro and in vivo biocompatibility, collagen undergoes rapid degradation 
upon implantation within 4-5 weeks (Donzelli et al. 2007). Furthermore, commercial 
collagen sponge (COLLAPLUG®) and membrane (BioGuide®, Geistlich Pharma, Wolhusen, 
Germany) induced considerable cell death, impaired initial function, and generated 
extraordinary intracellular reactive oxygen species in attached osteoblast cells. These effects 
substantially ameliorated after N-acetyl cysteine pre-treatment of the collagen sponge and 
membrane (Yamada et al. 2010). 
Collagen is very often used as matrix for application of growth factors, e.g. TGF- or BMP-2. 
Intramuscular application of TGF--loaded collagenous matrix is resulted in bone induction 
in primates (Ripamonti et al. 1997; Duneas et al. 1998). TERUPLUG®, as a carrier for 
Escherichia coli-derived recombinant human bone morphogenetic protein-2 (ErhBMP-2), 
was implanted into the calf muscle of Wistar rats. After 21 days, mature bone was formed 
and on days 14 to 21 after implantation, alkaline phosphatase activity and calcium content 
increased (Shinji et al. 2003). 
Examples for a commercially available product containing growth factors is INFUSE® Bone 
Graft (Medtronic GmbH, Meerbusch, Germany), recombinant human bone morphogenetic 
protein 2 in an absorbable collagen sponge. 
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4.4 Biocomposites containing flax fibers in a polyester matrix 
The usage of barrier membranes for osteogenesis has increased in the last years. Small bony 
defects seem not to depend on the application of membranes to regenerate bone, but large 
bone defects benefit from membranes, because they reduce the indispensable resorption of 
bone grafts when used alone. The application of barrier membranes to promote bone 
regeneration was described in orthopedic research. However, the clinical potential of these 
membranes was recognized some years ago for periodontal regeneration (Hermann and 
Buser 1996; Sculean et al. 2008).  
Fibre-reinforced plastics have successfully proven their value in various applications 
because of their excellent specific properties, such as high strength and stiffness. The use of 
natural fibres for fabrication of composites in combination with biodegradable polymers is 
an excellent approach for biomedical application. Natural fibres are of basic interest since 
they have the capability to replace glass, ceramics or carbon fibres (Bax and Müssig 2008). 
Natural fibres combined with biodegradable polymers like polyhydroxyalkanoate (PHA), 
polylactic acid (PLA), polycaprolactone (PCL) and starch polymers frequently used as a 
matrix resulted in composites called “green” because of their complete biodegradability 
(Mohanty et al. 2005). The influence of plant fibres like flax, jute, ramie, oil palm fibres or 
cellulose fibres on the mechanical properties of biodegradable polymers was tested several 
years ago. Wollendorfer and Bader found in increased tensile strength as well as a four 
times better wheat starch of the reinforced polymer compared to the polymers without 
fibres (Wollendorfer and Bader 1998) Composites reinforced with natural fibres have been 
used in several branches of industry (i.e. automobile) and medicine with special focus on 
tissue artificial scaffold, drug-release systems, cardiovascular patches and nerve cuffs 
(Williams and Martin 2002; Misra et al. 2006). Flax fibres are amongst the oldest fibre crops 
in the world. The use of flax for the production of linen goes back at least to ancient 
Egyptian times. It is known that flax fibres are stronger than cotton fibres but less elastic. 
Flax fibres provide natural raw materials for composites and pulp / paper (van Dam et al. 
1996). Former studies have shown an increased biological reaction around linen threads 
compared to synthetic threads (Jarosz-Cichulska 1988). Recently, the cytotoxicity of flax 
fibres, oil emulsion, and seedcake extract from transgenic flax overproducing various 
antioxidative compounds was determined in a culture of mouse fibroblasts. No changes in 
the total number of fibroblasts and comparable numbers of dead cells were shown in the 
presence of each type of flax material (Skorkowska-Telichowska et al. 2010).  
In order to improve the biochemical and mechanical properties of flax fibres, transgenic flax 
over-expressing the bacterial polyhydroxybutyrate (PHB) gene was produced (Wrobel et al. 
2004; Wrobel-Kwiatkowska et al. 2007). Composites containing fibres from transgenic plants 
did not differ from the control plants in the level of major fibre constituents (i.e. cellulose, 
lignin and pectin content) but was significantly stronger and more elastic than those 
containing fibres from control flax plants (Szopa et al. 2009). Furthermore, genetically 
modified flax plants producing PHB showed significantly increased parameters such as 
strength, Young´s modulus, energy for failure of flax fibres and phenolic acid level, a reason 
for improved plant resistance to pathogen infection (Wrobel-Kwiatkowska et al. 2007; 
Wrobel-Kwiatkowska et al. 2009). 
We found that composites containing flax fibres from transgenic flax plants producing 
polyhydroxybutyrate (M50) and control (wt-Nike) plants in a polylactid (PLA) or 
polycaprolactone (PCL) matrix showed a good in vitro biocompatibility despite the cell 
viability of mouse fibroblast cells treated with these composites being slightly reduced and 
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the amount of dead cells significantly increased compared to untreated cells after incubation 
for 12h to 48h. The biocompatibility of composites from transgenic flax plant fibres 
producing PHB did not differ from composites of non-transgenic flax plant fibres. Both linen 
membranes coated with PLA showed a significant increase in the proliferation rate of 
fibroblast cells compared to cells treated with membranes composed of PLA alone, whereas 
both flax membranes in the PCL matrix significantly decreased the proliferation rate of 
mouse fibroblast cells compared to cells treated with membranes composed of PCL alone. 
No differences were found between genetically modified and non-modified flax (Figure 8). 
 
 
Fig. 8. Determination of cell viability by measurement of ATP. Viability of mice fibroblast 
cells (L929) cultured without and with membranes produced of polylactide (PLA), linen 
from PHB producing flax fibres coated with PLA (PLA-M50), linen from normal flax fibres 
coated with PLA (PLA-NIKE), polycaprolactone (PCL), linen from PHB producing flax 
fibres coated with PCL (PCL-M50) and linen from normal flax fibres coated with PCL (PCL-
NIKE) for 24h was analysed using the CellTiter-Glo® assay. Means ± S.E.M. are given in all 
cases for n = 14-48 samples. Stars indicate significant differences: ***) p < 0.005, membrane-
treated cells versus control; ##) p < 0.01, ###) p < 0.005, PLA versus linen membrane, +) p < 
0.05, PCL versus linen membrane, unpaired t-test. RLU = relative luminescence units. 
Beside macroscopically and histological examination the biocompatibility can be assessed by 
analyses of the biomaterial influence on the gene expression. Because of this we analysed the 
gene expression of growth factors such as vascular endothelial growth factor (VEGF) and 
insulin-like growth factor (IGF) as well as myostatin also known as growth differentiation 
factor 8 (GDF8) after subcutaneous implantation. We found that subcutaneously insertion of 
the different biocomposites had no influence on the gene expression of the most tested 
genes. The constantly happening muscle contraction of the Musculus latissimus dorsi is not 
followed by stress-induced changes in muscle growth factor expression (Gredes et al. 
2010b). The influence of the new biocomposites on bone regeneration must be checked using 
in vitro models. Cell culture experiments with primary osteoblast cells and these 
biocomposites showed that osteoblast cells are able to attach and proliferate on these 
membranes. The proliferation is much better on PLA-biocomposites compared to PCL-flax 
membranes (Figure 9). 
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Fig. 9. Scanning electron micrographs of osteoblast cells (PO62) growing on a PCL-M50 (A) 
or a PLA-M50 membrane (B). After 10 days of cell culture on PCL-M50 membranes 
moderate natural cover with osteoblast cells could be observed, whereas culturing on PLA-
M50 increased the amount of growing cells. Bars = 300 µm 
4.5 Carrier for growth factors 
As described earlier in this chapter bone formation is mediated by the release of local, 
biochemical and biophysical messengers, e.g. growth factors. In therapeutic use the bone 
growth factors need a carrier. Carrier requirements for most bone repairs are also simplified 
by the concurrent use of either internal or external fixation or coaptation, eleminating the 
need for mechanical strenght or resistance to motion. Furthermore, the carrier should assure 
local, sustained release of the growth factors which may otherwise be rapidly absorbed 
before instituting their effect. Bone is also highly vascular and carriers used for bone repair 
have to be capable of supporting vascular in-growth. Several biodegradable materials have 
been investigated as carriers for bone growth factors, including (1) organic materials such as 
inactive demineralized bone proteins, collagen, fibrin, squalene, and coral; (2) ceramics, 
including tricalcium phosphate, hydroxyapatite, calcium-sulphate composites, and bioactive 
glasses; and (3) synthetic polymers such as polylactide, polylactide-polyglycolide co-
polymer, polyanhydride, and polyorthoester (Table 2). 
PLA-M50 
PCL-M50 
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Biodegradable materials as 
carriers for bone growth 
factors 
Quality characteristics References 
 
 
 
 
 
 
organic 
materials 
 
collagen
 
 
 
 
 
 
 
 
 
fibrin  
 
 
 
 
coral   
 
 
Collagen molecules assemble into 
heterotypic aggregates that define 
the biological and mechanical 
properties of most tissues and 
organs. Type I collagen, the major 
component of the organic bone 
matrix can bind osteoblasts via 
specific cell surface receptors, the 
integrins. 
 
High adhesion to many biological 
surfaces, excellent seeding effects 
and good tissue development. It is 
not toxic, allergenic or inflammatory. 
 
Natural coral is radiodense, it 
resorbs more rapidly than ceramic 
materials and the natural pore size of 
native coral facilitates 
osteoconduction and bone growth.
(Burgeson and 
Nimni 1992; 
Tzaphlidou 
2005) 
 
 
 
 
 
 
(Ye et al. 2000) 
 
 
 
 
(Sciadini et al. 
1997) 
 
 
 
 
 
 
 
 
 
ceramics 
 
tricalcium 
phosphate  
 
 
 
 
hydroxyapatite  
 
 
 
 
 
 
 
calcium-sulphate 
composites   
 
 
 
bioactive glass 
 
Porous beta-tricalcium phosphate 
scaffolds are employed for local drug 
delivery in bone. It is used alone or 
in combination with resorbable 
polymer or autologous materials.  
 
An identical composition to the bone 
tissue of living organisms and has 
similar physical, mechanical, and 
other properties. It shows high 
biocompatibility, does not give rise 
to inflammatory phenomena, and is 
non-toxic. 
 
Calcium sulfate (plaster of Paris) is 
an absorbable, moldable material 
that has easy handling properties. It 
promotes osseous formation.  
 
This material has osteoconductive 
and osteo-promotive abilities in the 
biocompatible interface for osseous 
migration, and a bioactive surface 
colonized by osteogenic cells free in 
the surgical wound. It bonds to soft 
and osseous tissues. 
(Bansal et al. 
2009; Kundu et 
al. 2010) 
 
 
 
 
(Yarosh et al. 
2001) 
 
 
 
 
 
 
(Pecora et al. 
1997) 
 
 
 
 
(Wilson and 
Low 1992; 
Macedo et al. 
2004) 
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synthetic 
polymers 
 
polylactide
(PLA) 
 
 
 
 
 
 
 
 
 
polylactide-
polyglycolide 
copolymer  
 
 
 
 
 
polyanhydride 
 
 
 
 
 
 
 
 
 
polyorthoester 
 
 
 
Prosperities of PLA depend on the 
component isomers, processing 
temperature and molecular weight. 
In nature, polymer degradation is 
induced thermal activation, 
hydrolysis, biological activity, 
oxidation, photolysis, or radiolysis. 
In biomedical fields it is also used as 
bone fixation material and drug 
delivery microsphere.   
 
It promotes specific cell adhesion, 
differentiation and bone formation. 
Its degradation depends on the 
formulation, amorphous/crystalline 
structure, isomeric characteristics, 
molecular weight and amount of 
material used. 
 
Polyanhydrides and their 
degradation products have not been 
found to cause significant harmful 
responses and are considered to be 
biocompatible. In vivo, 
polyanhydrides degrade into non-
toxic diacid monomers that can be 
metabolized and eliminated from the 
body. 
 
This polymer degrades at its surface 
and becomes thinner with time 
rather than crumbling. It can cause 
minor moderate inflammation 
reaction, compared with PLA.
(Zhao et al. 
2004; 
Madhavan 
Nampoothiri et 
al. 2010) 
 
 
 
 
 
 
(Lu et al. 2003; 
Serino et al. 
2003)  
 
 
 
 
 
(Tamada and 
Langer 1992; 
Kumar et al. 
2002) 
 
 
 
 
 
 
(Ekholm et al. 
1997) 
Table 2. Carrier materials for bone growth factors. 
5. Conclusion 
The literature has shown that early bone loss can be significantly reduced by socket grafting. 
The process of socket grafting requires an understanding of wound healing and an 
appreciation of the biological properties of the products available for socket grafting. Various 
types of alloplastic bone substitution materials have been created and showed ossification and 
new bone formation. The huge variety of biomaterials makes it difficult to decide which 
material is adequate for which indication. To date, tissue engineered bone is far from a routine 
clinical application. Clinical investigations using alloplastic bone substitution materials are 
very rare in the literature but, because of similar bone remodelling processes in pigs and 
humans, we found the same details about usage of alloplasts in dentistry. The most alloplastic 
materials are not popular in dentistry and, because of this, further studies are necessary. 
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